Epstein Secrets

le (KY) Courier-Journal (9/30, 368K) reports Cameron had asked for a one-week extension in a motion filed Tuesday. The Washingtnn Past (9/30, Iati, Berman, Knowles, 14.2M) and New Ynrk Times (9/30, Wright, Bogel- Burroughs, 18.61M), among other news outlets, also report the delay. Seagram's Heiress Sen

ustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v

lle (no Courier-Journal (9/30, 368K) reports Cameron had asked for a one-week extension in a motion filed Tuesday. The Washington Post (9/30, Iati, Berman, Knowles, 14.2M) and New York Times (9/30, Wright, Bogel-Burroughs, 18.61M), among other news outlets, also report the delay. Seagram's Heiress Sen

nsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v

le (KY) Courier-Journal (9/30, 368K) reports Cameron had asked for a one-week extension in a motion filed Tuesday. The Washington Post (9/30, Iati, Berman, Knowles, 14.2M) and New York Times (9/30, Wright, Bogel-Burroughs, 18.61M), among other news outlets, also report the delay. Seagram's Heiress Sen

ustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v